Author(s): Ohigashi Y, Sho M, Yamada Y, Tsurui Y, Hamada K, et al.
Purpose: The negative regulatory programmed death-1/programmed death-1 ligand (PD-1/PD-L) pathway in T-cell activation has been suggested to play an important role in tumor evasion from host immunity. In this study, we investigated the expression of PD-L1 and PD-L2 in human esophageal cancer to define their clinical significance in patients' prognosis after surgery. Experimental Design:PD-L1 and PD-L2 gene expression was evaluated in 41 esophagectomy patients by real-time quantitative PCR. The protein expression was also evaluated with newly generated monoclonal antibodies that recognize human PD-L1 (MIH1) and PD-L2 (MIH18). Results: The protein and the mRNA levels of determination by immunohistochemistry and real-time quantitative PCR were closely correlated. PD-L–positive patients had a significantly poorer prognosis than the negative patients. This was more pronounced in the advanced stage of tumor than in the early stage. Furthermore, multivariate analysis indicated that PD-L status was an independent prognostic factor. Although there was no significant correlation between PD-L1 expression and tumor-infiltrating T lymphocytes, PD-L2 expression was inversely correlated with tumor-infiltrating CD8+ T cells. Conclusions: These data suggest that PD-L1 and PD-L2 status may be a new predictor of prognosis for patients with esophageal cancer and provide the rationale for developing novel immunotherapy of targeting PD-1/PD-L pathway.
Referred From: https://dx.doi.org/10.1158/1078-0432.CCR-04-1469
Author(s): Riaz SP, LÃ¼chtenborg M, Coupland VH, Spicer J, Peake MD, et al.
Author(s): Meza R, Meernik C, Jeon J, Cote ML
Author(s): Altan M, Chiang AC
Author(s): Shi Y, Xing P, Fan Y, Zhang X, Hu C, et al.
Author(s): Muenst S, Soysal SD, Tzankov A, Hoeller S
Author(s): Ohaegbulam KC, Assal A, Lazar-Molnar E, Yao Y, Zang X
Author(s): Qin T, Zeng YD, Qin G, Xu F, Lu JB, et al.
Author(s): Schmidt LH, KÃ¼mmel A, GÃ¶rlich D, Mohr M, BrÃ¶ckling S, et al.
Author(s): Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, et al.
Author(s): Herbst RS, Soria JC, Kowanetz M, Fine GD, Hamid O, et al.
Author(s): Micke P, Faldum A, Metz T, Beeh KM, Bittinger F, et al.
Author(s): Muenst S, Schaerli AR, Gao F, DÃ¤ster S, Trella E, et al.
Author(s): Schalper KA, Velcheti V, Carvajal D, Wimberly H, Brown J, et al.
Author(s): Ali HR, Glont SE, Blows FM, Provenzano E, Dawson SJ, et al.
Author(s): Wang A, Wang HY, Liu Y, Zhao MC, Zhang HJ, et al.
Author(s): Azuma K, Ota K, Kawahara A, Hattori S, Iwama E, et al.
Author(s): Zhang Y, Wang L, Li Y, Pan Y, Wang R, et al.
Author(s): Ishii H, Azuma K, Kawahara A, Yamada K, Imamura Y, et al.
Author(s): Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, et al.